Amgen Inc. share price logo

Amgen Inc. Share Price

NASDAQ: AMGN

Large Cap

$283.86

-3.06

(-1.07%)

as on

Amgen Inc. Stock Performance

as on September 4, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $280.38
    $286.12
    downward going graph

    1.23%

    Downside

    0.80%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $253.3
    $339.17
    downward going graph

    10.77%

    Downside

    19.48%

    Upside

    downward going graph

Amgen Inc. share price movements today

Previous Close
$286.92
Open
$285.13
Volume
1.5M
Day's Low - High
$280.38 - $286.12
52 Week Low - High
$253.3 - $339.17

Amgen Inc. Historical Returns

1 Month Return
-3.09 %
3 Month Return
-0.64 %
1 Year Return
-12.95 %
3 Year Return
+ 18.71 %
5 Year Return
+ 16.05 %

Amgen Inc. Stock Fundamentals & Key Indicators

Check Amgen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$154.5B

EPS (TTM)

21.0734

Dividend Yield

2.63%

Quarterly Earnings Growth YOY

0.92%

PE Ratio (TTM)

23.48

Industry PE ratio

15.08

P/B Ratio

23.4795

PEG Ratio

0.924

EBITDA

16.1B

Revenue (TTM)

34.9B

Profit Margin

18.96%

Return On Equity TTM

99.14%

Amgen Inc. Stock Valuation

Track how Amgen Inc. P/E has moved over time to understand its valuation trends.

Amgen Inc. in the last 5 years

  • Overview

  • Trends

Lowest (12.34x)

December 31, 2021

Industry (15.08x)

September 3, 2025

Today (23.48x)

September 3, 2025

Highest (17.02x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 23.48x

Amgen Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amgen Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$154.5B16.05%23.4818.96%
BUY$659.1B391.6%48.0225.91%
BUY$374.4B129.02%100.916.45%
BUY$248.7B73.51%14.5135.61%
BUY$428.8B18.47%19.0425.00%

Stock Returns calculator for Amgen Inc. Stock including INR - Dollar returns

The Amgen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Amgen Inc. investment value today

Current value as on today

₹90,805

Returns

₹9,195

(-9.2%)

Returns from Amgen Inc. Stock

₹14,115 (-14.11%)

Dollar Returns*

₹4,919 (+4.92%)

Analyst Recommendation on Amgen Inc. Stock

Based on 37 analysts

BUY

56.76%

Buy

35.14%

Hold

8.11%

Sell

Based on 37 analysts, 56.76% of analysts recommend a 'BUY' rating for Amgen Inc.. Average target price of $311.88

Amgen Inc. Share Price Target

Get share price movements and forecasts by analysts on Amgen Inc..

What analysts predicted

8.98%UPSIDE

Target Price

$311.88

Current Price

$283.86

Analyzed by

37 Analysts

Target

$311.88

Amgen Inc. target price $311.88, a slight upside of 8.98% compared to current price of $283.86. According to 37 analysts rating.

Amgen Inc. Stock's Interest Amongst Investors

Investment in Amgen Inc. Shares on INDmoney has grown by 21.73% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:21.73% versus previous 30 day period

Search interest for Amgen Inc. Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:16% versus previous 30 day period

Amgen Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
6,105
6,986
6,903
8,196
7,447
8,388
8,503
9,086
8,149
9,167
Gross Profit
4,385
5,173
5,097
5,084
4,247
5,152
5,193
5,974
5,181
6,156
Operating Income
1,921
2,684
2,021
1,271
991
1,909
2,047
2,311
1,178
2,644
EBITDA
4,885
3,262
3,601
3,053
2,155
3,002
5,273
2,926
4,083
3,617
Interest Expense
543
752
759
821
824
808
776
747
723
708
Depreciation
900
896
895
1,380
1,399
1,400
1,396
1,397
1,387
1,341
Income Before Tax
3,442
1,614
1,947
852
-68
794
3,101
782
1,973
1,568
Income Tax Expense
601
235
217
85
45
48
271
155
243
136
Net Income
2,841
1,379
1,730
767
-113
746
2,830
627
1,730
1,432
Net Profit Margin
46.54%
19.74%
25.06%
9.36%
-1.52%
8.89%
33.28%
6.90%
21.23%
15.62%

Amgen Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
21,662
22,991
22,849
23,747
23,362
25,424
25,979
26,323
28,190
33,424
Gross Profit
17,435
18,829
18,780
19,646
19,006
19,265
19,525
19,917
19,739
20,566
Operating Income
8,470
9,794
9,973
10,263
9,674
9,139
7,639
9,566
7,897
7,258
EBITDA
11,181
12,528
12,856
12,883
12,633
12,996
11,296
12,169
7,897
13,356
Interest Expense
1,095
1,260
1,304
1,392
1,289
1,262
1,197
1,406
2,875
3,155
Depreciation
-
-
1,955
1,946
2,206
3,601
3,398
3,417
3,602
5,592
Income Before Tax
7,978
9,163
9,597
9,545
9,138
8,133
6,701
7,346
7,855
4,609
Income Tax Expense
1,039
1,441
7,618
1,151
1,296
869
808
794
1,138
519
Net Income
6,939
7,722
1,979
8,394
7,842
7,264
5,893
6,552
6,717
4,090
Net Profit Margin
32.03%
33.59%
8.66%
35.35%
33.57%
28.57%
22.68%
24.89%
23.83%
12.24%

Amgen Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
1,379
1,730
767
-113
746
2,830
627
1,730
1,432
Operating Cash Flow
4,109
2,760
538
689
2,459
3,571
4,771
1,391
2,280
Investing Cash Flow
-211
-262
-27,089
-217
-217
-210
-402
-447
-389
Financing Cash Flow
-1,210
-2,005
2,754
-1,708
-2,649
-3,651
-1,407
-4,107
-2,673
Change in Cash
2,688
493
-23,797
-1,236
-407
-290
2,962
-3,163
-782

Amgen Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
7,722
1,979
8,394
7,842
7,264
5,893
6,552
6,717
4,090
Operating Cash Flow
10,354
11,177
11,296
9,150
10,497
9,261
9,721
8,471
11,490
Investing Cash Flow
-8,658
-4,024
14,339
5,709
-5,401
733
-6,044
-26,204
-1,046
Financing Cash Flow
-2,599
-6,594
-22,490
-15,767
-4,867
-8,271
-4,037
21,048
-9,415
Change in Cash
-903
559
3,145
-908
229
1,723
-360
3,315
1,029

Mutual Funds that own Amgen Inc. Stock

Check out the Mutual Funds with significant holdings in Amgen Inc..

Global Institutional Holdings in Amgen Inc.

Funds
Holdings
Vanguard Group Inc
9.82%
BlackRock Inc
8.44%
State Street Corp
5.42%
Capital World Investors
3.1%
Morgan Stanley - Brokerage Accounts
3.02%

Amgen Inc. News & Key Events

  • img

    Today's Timeline - 28 August

    Thu, 10:09 AM

    -

    Amgen reports $155 billion market cap and 14.6% annual revenue growth, with strong free cash flow margin of 29.8%.

    Thu, 12:36 PM

    -

    Leerink Partners maintains a Hold rating on Amgen, citing growth potential for Repatha but significant long-term risks.

    Thu, 04:41 PM

    -

    Veeva Systems collaborates with Amgen to enhance clinical trial efficiency using the Veeva Clinical Platform.

Insights on Amgen Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Amgen Inc. has shown positive revenue growth over the last two quarters. The revenue increased from $8.14 billion to $9.16 billion, which represents an average increase of 11.1% per quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly And Company has given 55.5% return, outperforming this stock by 37.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Abbvie Inc has given 7.2% return, outperforming this stock by 20.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Amgen Inc. has experienced a decline in its net profit over the last two quarters. Specifically, the net profit decreased from $1.73 billion to $1.43 billion. This represents an average decrease of 17.2% per quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, AMGN stock has moved down by -3.4%

About Amgen Inc.

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
OrganisationAmgen Inc.
HeadquartersOne Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
IndustryHealth Technology
CEOMr. Robert A. Bradway
E-voting on sharesClick here to vote

Key Management of Amgen Inc.

Name

Title

Dr. David M. Reese M.D.

Executive VP & CTO

Mr. Murdo Gordon

Executive Vice President of Global Commercial Operations

Dr. James E. Bradner M.D.

Executive Vice President of Research & Development

Mr. Matthew C. Busch

Chief Accounting Officer & VP of Finance

Mr. Howard Y. Chang M.D., Ph.D.

Senior VP of Global Research & Chief Scientific Officer

Mr. Robert A. Bradway

Chairman, CEO & President

Mr. Peter H. Griffith

Executive VP & CFO

Mr. Esteban Santos

Executive Vice President of Operations

Mr. Scott Skellenger

Senior VP & Chief Information Officer

Justin G. Claeys

Vice President of Investor Relations

FAQs

What is Amgen Inc. share price today?

Amgen Inc. share price today is $283.86 as on at the close of the market. Amgen Inc. share today touched a day high of $286.12 and a low of $280.38.

What is the 52 week high and 52 week low for Amgen Inc. share?

Amgen Inc. share touched a 52 week high of $339.17 on and a 52 week low of $253.3 on . Amgen Inc. stock price today i.e. is closed at $283.86,which is 16.31% down from its 52 week high and 12.06% up from its 52 week low.

What is Amgen Inc.'s market capitalisation today?

Amgen Inc. market capitalisation is $0.15T as on .

How to invest in Amgen Inc. Stock (AMGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amgen Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amgen Inc. Shares that will get you 0.0053 shares as per Amgen Inc. share price of $283.86 per share as on September 4, 2025 at 1:29 am IST.

What is the minimum amount required to buy Amgen Inc. Stock (AMGN) from India?

Indian investors can start investing in Amgen Inc. (AMGN) shares with as little as ₹88.035 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.35 in Amgen Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Amgen Inc. share’s latest price of $283.86 as on September 4, 2025 at 1:29 am IST, you will get 0.0352 shares of Amgen Inc.. Learn more about fractional shares .

What are the returns that Amgen Inc. has given to Indian investors in the last 5 years?

Amgen Inc. stock has given 16.05% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?